Advanced design, materials and processes enabling high-volume manufacturing of next generation heart monitoring sensor
Project duration: Q1 2021- Q4 2023
Project Owner: Cardiaccs AS
Project description/ background:
The overall idea of the AMPliSens project is to enable high volume manufacturing of the next generation heart monitoring sensor through advanced design, a lean process and with new materials. The manufacturing will be done with a design and material selection aiming to increase the production rate, lower the cost and make the production more automated. The ultimate result is a medical device that improves outcomes for patients undergoing open heart surgery and increases health economic benefits.
The primary objective of the project is to develop a novel and game changing process with the right materials and design that increase the production rate, lower the production cost and make the manufacturing process more automated for the next generation heart monitoring sensor. The most challenging R&D challenge will be to combine an optimal combination of materials for a new production process with optimal design of the sensor.
Cardiaccs has already developed a proprietary sensor – CardiSense™ – consisting of an accelerometer coupled with standard temporary pacemaker electrodes placed on the heart surface during cardiac surgery, for a real time and accurate measurement of the cardiac function.
Together with Norner Research, Cardiaccs wants to create a cost-efficient and scalable process for the next generation sensor to improve patient outcomes for a larger patient group. With a successful establishment of a high volume manufacturing process, the foundation is laid for a product which can be used in all open-heart surgeries. The AMPliSens project will be crucial to position Cardiaccs as a market leader in the cardiac monitoring devices’ segment.
The project will allow Cardiaccs to understand key manufacturing processes and establish manufacturing know-how of high risk medical device. This will secure a higher competence level in-house and establish the company in a competitive position in the field of medical device research, development and manufacturing. Finally, if the project succeeds in dramatically reducing manufacturing costs, this can enable access to the CardiSense technology for a larger patient group, improving the cost / benefit ratio of the product.